TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01827956 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study NCT01827956 — Predictive Biomarker (PRD): FCGR2A mRNA
Genes: FCGR2A; CD32; FCG2; FCGR2A1; IGFR2
Study NCT01073826 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01138683 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01138683 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02675543 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04315415 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00005916 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01761630 — Predictive Biomarker (PRD): FPR2 mRNA
Genes: FPR2; FPRH1; FPRL1; LXA4R
Study NCT04506827 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00963209 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03730675 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT04632732 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04632732 — Predictive Biomarker (PRD): APLNR mRNA
Genes: APLNR; AGTRL1; APJ
Study NCT04632732 — Predictive Biomarker (PRD): APLN mRNA
Genes: APLN; APEL
Study NCT04632732 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study NCT01263106 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02105376 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study NCT00006134 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00006134 — Safety Biomarker (SAF): Interleukin 1
Study NCT04053322 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04248842 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003870 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT02903277 — Predictive Biomarker (PRD): ITK mRNA
Genes: ITK; EMT; LYK
Study NCT00411944 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00411944 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00411944 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT04552574 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01227317 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01227317 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT01227317 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT01227317 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT04627246 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03519178 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03519178 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03519178 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03519178 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01752985 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00551174 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00205660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01263977 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01828736 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00000546 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01187862 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01187862 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT01187862 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01187862 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01187862 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01187862 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study NCT01187862 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04278469 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01082653 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04530929 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03969901 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study NCT02785913 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00551447 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03901014 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03764423 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02377960 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01382966 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Sclerostin
Genes: SOST; UNQ2976/PRO7455/PRO7476
Study NCT04156893 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04070677 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04414956 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03385473 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03385473 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study NCT03385473 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03385473 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT04287881 — Safety Biomarker (SAF): MTHFR
Study NCT00001337 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00001337 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04648475 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04648475 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01952925 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00931879 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00368277 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01536743 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT02649270 — Predictive Biomarker (PRD): CD6 mRNA
Genes: CD6
Study NCT00628056 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03076320 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03076320 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00313118 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02122172 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02122172 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02122172 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00533897 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04686006 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT02010047 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05490914 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02911857 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01524757 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT03037879 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01226316 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT01226316 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01226316 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02853045 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02577159 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03792321 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02635321 — Predictive Biomarker (PRD): GMPPB mRNA
Genes: GMPPB
Study NCT03967249 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study NCT03967249 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT03967249 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03258931 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00010439 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00518128 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00005685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01127542 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00395681 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04559009 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00567307 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00884858 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00884858 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01545635 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01030536 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03431090 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02273362 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01829698 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT00696735 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03605589 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03605589 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01987596 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT04493450 — Predictive Biomarker (PRD): IKBKG mRNA
Genes: IKBKG; FIP3; NEMO
Study NCT03644355 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01634503 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01833585 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01476956 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01521559 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01300247 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01999868 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT01635517 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00516685 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00034541 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03947801 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03947801 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04412252 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00084162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03875079 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT03875079 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03756077 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01625442 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01446978 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00536185 — Predictive Biomarker (PRD): ALOX5 mRNA
Genes: ALOX5; LOG5
Study NCT00114530 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02450591 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02623023 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02623023 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00091598 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02735746 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00566995 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT00617526 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02711397 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT04851080 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04360811 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00102115 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00094705 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01273597 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01273597 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01403766 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01403766 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04212039 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study NCT04361318 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01918384 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02302807 — Predictive Biomarker (PRD): UBC mRNA
Genes: UBC
Study NCT01850706 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00771069 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05398406 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03974191 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT00035997 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00035997 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02136810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03069443 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00726375 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04614597 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04478513 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02276196 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01280253 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00871533 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT03298438 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04593940 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00214851 — Safety Biomarker (SAF): Interleukin 1
Study NCT03047863 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03047863 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01409044 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00185523 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02100839 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02215733 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04398693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05375149 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT05375149 — Predictive Biomarker (PRD): EBP mRNA
Genes: EBP
Study NCT01033760 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02448771 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02448771 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00806156 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT04393506 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04393506 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00544830 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03501875 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT01225913 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01819636 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01819636 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01365052 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT02421783 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02421783 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02903810 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04147702 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04383483 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04383483 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02710266 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00604071 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00258869 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT00258869 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study NCT00258869 — Predictive Biomarker (PRD): SLC25A10 mRNA
Genes: SLC25A10; DIC
Study NCT00258869 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00258869 — Predictive Biomarker (PRD): PELI1 mRNA
Genes: PELI1; PRISM
Study NCT04152473 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT02493816 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT00436566 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00444626 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03441711 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03441711 — Predictive Biomarker (PRD): GADD45A mRNA
Genes: GADD45A; DDIT1; GADD45
Study NCT03213522 — Predictive Biomarker (PRD): SEMG1 mRNA
Genes: SEMG1; SEMG
Study NCT03126461 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06190600 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01597960 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00471536 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01897961 — Predictive Biomarker (PRD): PLA2R1 mRNA
Genes: PLA2R1; CLEC13C
Study NCT03747458 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT01074177 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01074177 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03267017 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04010695 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT01235689 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03026361 — Predictive Biomarker (PRD): IGF2 mRNA
Genes: IGF2; PP1446
Study NCT03026361 — Predictive Biomarker (PRD): IGF2R mRNA
Genes: IGF2R; MPRI
Study NCT00223665 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00332280 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT01206075 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01206075 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02807519 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02856035 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT04397601 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04397601 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT04397601 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT04397601 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study NCT04397601 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT04397601 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04397601 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT04397601 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03475823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04249843 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT00006864 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02474264 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04067674 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04094129 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01259856 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05097274 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05097274 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05097274 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT05097274 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT05097274 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT05097274 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT00057889 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02993757 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04842058 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01766596 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00731627 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT02518256 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04926428 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00575900 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01051063 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT03892096 — Monitoring Biomarker (MOI): Cell-free DNA